Marksans Pharma gets USFDA approval for Esomeprazole Magnesium Capsules
Source: Business Standard Mumbai-headquartered pharma company Marksans Pharma announced on Tuesday that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC). Esomeprazole, the active ingredient in these capsules, is used for treating various stomach and […]
AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US
Source: Financial Express The agreements effectively resolve all pending claims filed against the company for failing to warn patients about the risk of contracting chronic kidney disease and related issues Pharma major AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn drug Prilosec in the […]